President and COO Matthew Korenberg sells 18,858 shares of Ligand …
On August 26, 2024, Matthew Korenberg, President & Chief Operating Officer of Ligand Pharmaceuticals Inc (NASDAQ:LGND), sold 18,858 shares of the company’s stock. The transaction was performed at a price of $105.34 per share, as detailed in the SEC filing. Following this sale, the insider now owns 49,510 shares of Ligand Pharmaceuticals Inc. Ligand Pharmaceuticals […]
